No action required for investors unless they wish to change a prior vote. The correction does not affect the substance of any proposals.
Price Chart
Executive Summary
NRx Pharmaceuticals, Inc. filed a supplement to its definitive proxy statement for its 2026 annual meeting, correcting the numbering of proposals on the proxy card and cover letter. The meeting will address director elections, executive compensation, an incentive plan amendment, and auditor ratification. The filing is routine and administrative, with no material financial or strategic changes.
Key Facts
- Filed a supplement to correct proposal numbering on the proxy card and cover letter for the 2026 annual meeting.
- Proposal 2 (executive compensation) was corrected to Proposal 4.
- Proposal 3 (incentive plan amendment) was corrected to Proposal 2.
- Proposal 4 (auditor ratification) was corrected to Proposal 3.
- All other information in the proxy statement remains unchanged.
- The board recommends voting 'For' on all proposals.
Financial Impact
No financial impact. This is a clerical correction to document numbering.
Risk Factors
- None. This is a routine administrative filing with no material risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001437749-26-005362 |
| Document: 0001437749-26-005362-index-headers.html | 0001437749-26-005362 |
| Document: 0001437749-26-005362-index.html | 0001437749-26-005362 |
| Document: 0001437749-26-005362.txt | 0001437749-26-005362 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $3.35 $3.16 | ▼ −5.67% | ▼ −8.24% | $2.90 (−13.28%) |
Sep 14, 2026 18d ago | 8-K | $3.49 $3.29 | ▼ −5.73% | ▼ −5.84% | $2.90 (−16.76%) |
Aug 17, 2026 6w ago | 8-K | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 17, 2026 6w ago | Press Release | $3.43 $3.45 | ▲ +0.58% | ▲ +1.77% | $2.90 (−15.31%) |
Aug 7, 2026 8w ago | 8-K | $3.58 $3.27 | ▼ −8.66% | ▼ −9.06% | $2.90 (−18.85%) |
Jul 22, 2026 10w ago | 8-K | $4.48 $3.23 | ▼ −27.90% | ▼ −25.50% | $2.90 (−35.16%) |
Jun 22, 2026 14w ago | Press Release | $3.90 $3.73 | ▼ −4.36% | ▼ −2.29% | $2.90 (−25.51%) |
Jun 5, 2026 17w ago | Press Release | $4.14 $3.84 | ▼ −7.25% | ▼ −7.82% | $2.90 (−29.83%) |
Jun 4, 2026 17w ago | Press Release | $4.14 $3.84 | ▲ +7.25% | ▲ +7.82% | $2.90 (+29.83%) |
Jun 3, 2026 17w ago | Press Release | $4.05 $3.76 | ▲ +7.16% | ▲ +3.34% | $2.90 (+28.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access